Latest Neuroimaging Stories
NeuroLogica is now offering Olea Medical’s perfusion analysis software for BodyTom® and CereTom®.
Reportbuyer.com just published a new market research report:
The global market for molecular imaging devices was valued at $2 billion in 2012 and is expected to reach $2.2 billion in 2013.
Patients with the most common form of focal epilepsy have widespread, abnormal connections in their brains that could provide clues toward diagnosis and treatment.
- Growing in low tufty patches.